510 related articles for article (PubMed ID: 10808206)
21. Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad HOC Working Group.
Denning DW; Donnelly JP; Hellreigel KP; Ito J; Martino P; van't Wout JW
Chemotherapy; 1992; 38 Suppl 1():43-9. PubMed ID: 1611930
[TBL] [Abstract][Full Text] [Related]
22. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
23. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
Wingard JR; Merz WG; Rinaldi MG; Johnson TR; Karp JE; Saral R
N Engl J Med; 1991 Oct; 325(18):1274-7. PubMed ID: 1669837
[TBL] [Abstract][Full Text] [Related]
24. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Goodman JL; Winston DJ; Greenfield RA; Chandrasekar PH; Fox B; Kaizer H; Shadduck RK; Shea TC; Stiff P; Friedman DJ
N Engl J Med; 1992 Mar; 326(13):845-51. PubMed ID: 1542320
[TBL] [Abstract][Full Text] [Related]
25. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M
Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359
[TBL] [Abstract][Full Text] [Related]
26. The prophylactic use of low-dose amphotericin B in bone marrow transplant patients.
Riley DK; Pavia AT; Beatty PG; Petersen FB; Spruance JL; Stokes R; Evans TG
Am J Med; 1994 Dec; 97(6):509-14. PubMed ID: 7985709
[TBL] [Abstract][Full Text] [Related]
27. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
Krüger W; Stockschläder M; Sobottka I; Betker R; De Wit M; Kröger N; Grimm J; Arland M; Fiedler W; Erttmann R; Zander AR
Leuk Lymphoma; 1997 Feb; 24(5-6):491-9. PubMed ID: 9086439
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of changes in fecal flora in patients preconditioned with either amphotericin B or fluconazole for allogeneic bone marrow transplantation.
Ashida T; Tsubaki K; Hasegawa H; Kanamaru A
Kansenshogaku Zasshi; 2000 Apr; 74(4):365-71. PubMed ID: 10835843
[TBL] [Abstract][Full Text] [Related]
29. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
30. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias.
Schaffner A; Schaffner M
J Infect Dis; 1995 Oct; 172(4):1035-41. PubMed ID: 7561177
[TBL] [Abstract][Full Text] [Related]
31. Amphotericin B infusion-related toxicity: comparison of two- and four-hour infusions.
Nicholl TA; Nimmo CR; Shepherd JD; Phillips P; Jewesson PJ
Ann Pharmacother; 1995 Nov; 29(11):1081-7. PubMed ID: 8573948
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.
Winston DJ; Pakrasi A; Busuttil RW
Ann Intern Med; 1999 Nov; 131(10):729-37. PubMed ID: 10577295
[TBL] [Abstract][Full Text] [Related]
33. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Ringdén O; Andström EE; Remberger M; Dahllöf G; Svahn BM; Tollemar J
Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772
[TBL] [Abstract][Full Text] [Related]
34. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
Gubbins PO; Bowman JL; Penzak SR
Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
[TBL] [Abstract][Full Text] [Related]
35. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
Brogden RN; Goa KL; Coukell AJ
Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
[TBL] [Abstract][Full Text] [Related]
36. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
Mehta J; Kelsey S; Chu P; Powles R; Hazel D; Riley U; Evans C; Newland A; Treleaven J; Singhal S
Bone Marrow Transplant; 1997 Jul; 20(1):39-43. PubMed ID: 9232254
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients.
Perfect JR; Klotman ME; Gilbert CC; Crawford DD; Rosner GL; Wright KA; Peters WP
J Infect Dis; 1992 May; 165(5):891-7. PubMed ID: 1569339
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Slavin MA; Osborne B; Adams R; Levenstein MJ; Schoch HG; Feldman AR; Meyers JD; Bowden RA
J Infect Dis; 1995 Jun; 171(6):1545-52. PubMed ID: 7769290
[TBL] [Abstract][Full Text] [Related]
39. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
40. Use of antifungal therapy in hospitalized patients. II. Results after the marketing of fluconazole.
Grasela TH; Pasko MT; Goodwin SD; Walawander CA; Blackwelder N; Bruder-Holt RJ
Ann Pharmacother; 1994 Feb; 28(2):261-70. PubMed ID: 8173148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]